MarketView
RXA MarketView
The tool provides comprehensive analysis for both NHS and pharmaceutical companies of the UK prescribing market, giving valuable insight down to CCG level.
With the RXA MarketView tool you can:
- Analyse up to 5 years of NHS prescribing and other sales data
- See data for all 20,000+ products prescribed by UK GPs, including branded and generic products
- See data for England, Wales, Scotland and Northern Ireland
- Select a range of reporting dimensions and filters
- SHA
- Area/CCG
- GP Practice
- Product
- Brand vs. Generic
- View extensive highly visual tables, charts and maps in the purpose-built dashboard
- Access easy to interpret analytics
- Export all data and graphics for ad-hoc analytics and report building – (E.g. Excel, CSV, jpeg and PDF)
Request your demonstration today
Andrew Norman, Director
We are working in an ever evolving industry where data increasingly drives marketing and sales activity. I believe RX Analyser is the most comprehensive analytics tool available for prescription data analysis. I can already see other business areas (within my company) that could really benefit.
Sales and Marketing Manager, Leading Healthcare Company, 2016
Need to analyse the community market? This tool can do that.
Senior Manager, Global Healthcare Company, 2016
The feature I like most? The ability to drill down to competitor sales.
Senior Manager, Global Healthcare Company, 2016
I use the data from RXA Budget Impact Model daily. It is the core of everything we do! I cannot recommend the model more. It has had a substantial impact on our business across the board and I would not be without it.
Country Manager UK, Leading Diagnostics Company
Customers tell us our platform has changed the way they work, that they’ve enhanced the strategies they implement, based on the work they’ve done with the analyser tool and that – bottom line – we’ve helped them to increase their sales. That’s a pretty good result from a chance cup of coffee.
Andrew Norman and David Warwick, Directors
Obviously I wouldn’t recommend Rx Analyser to our direct competitors as I believe the level of insight provided really gives us an edge.
